National Institute for Health & Care Excellence

NICE Approval Crizotinib.PNG
Crizotinib
Sept 2016
(first line)
Certitinib pic 2nd line.jpg
Ceritinib
Jun 2018
(after Crizotinib)
Lorlatinib.JPG
Lorlatinib
May 2020
(previously treated)
NG 12 pic.JPG
Cancer
Recognition
& Referral
Criz pre.JPG
Crizotinib
Dec 2016
(previously treated)
NICE Approval Alectinib.PNG
Alectinib
Aug 2018
(first line)
bRIG FIRST.JPG
Brigatinib
Nov 2020
(first line)
NG 122 pic.JPG
Lung Cancer
Diagnosis &
Management
NICE Approval Ceritinib.PNG
Ceritinib
Jan 2018
(first line)
Brig.JPG
Brigatinib
March 2019
(after Crizotinib)
BRIG AFTER a &c.JPG
Brigatinib
(after Cerit/Alect)
Suspended
SMC.jpeg
Lorlatinib approved for 1st line use in Scotland March 2022

Summary

TKI Pathways Takeda.jpg